In Parkinson’s disease (PD) and related disorders pathological alpha-synuclein has been discussed to propagate via a prion-like mechanism in the CNS. The application of exogenous alpha-synuclein fibrils via injection to animal models of PD has been shown to be a useful method to study prion-like propagation of pathological alpha-synuclein and of transmission pathways that play a critical role in recapitulating characteristics of synucleinopathies. Using bigenic mice expressing mutant human alpha-synuclein in neurons and firefly luciferase in astrocytes we showed that transmission via the tongue and the peritoneum represent entrance points for pathological alpha-synuclein to invade the CNS. Here we present a method to quantify astrogliosis b...
Abstract Abnormal accumulation of alpha-synuclein (αsyn) is a pathological hallmark of Lewy body rel...
International audienceIn Parkinson's disease, some of the first alpha-synuclein aggregates appear in...
In Parkinson's disease, some of the first alpha-synuclein aggregates appear in the olfactory system ...
Bioluminescence imaging in transgenic mice expressing firefly luciferase in Doublecortin+ (Dcx) neur...
Abstract Background Rat models of Parkinson’s disease...
Abstract Background Rat models of Parkinson’s disease...
alpha-Synuclein is a soluble, cellular protein that in a number of neurodegenerative diseases, inclu...
Abstract Background Experimental autoimmune encephalomyelitis is a widely used animal model to under...
Alpha-synuclein (αSyn) is encoded by the first causal gene identified in Parkinson's disease (PD) an...
With more than thousand disorders of the brain and nervous system, affecting up to one billion peopl...
With more than thousand disorders of the brain and nervous system, affecting up to one billion peopl...
Parkinson's disease is a neurodegenerative disorder affecting the doparminergic neurons in the subst...
Alpha-synuclein (αSYN) aggregation plays a pivotal role in the pathogenesis of Parkinson's disease a...
Abstract Background Parkinson’s disease (PD) is a neurodegenerative disease characterized by intrane...
International audienceIn Parkinson's disease, some of the first alpha-synuclein aggregates appear in...
Abstract Abnormal accumulation of alpha-synuclein (αsyn) is a pathological hallmark of Lewy body rel...
International audienceIn Parkinson's disease, some of the first alpha-synuclein aggregates appear in...
In Parkinson's disease, some of the first alpha-synuclein aggregates appear in the olfactory system ...
Bioluminescence imaging in transgenic mice expressing firefly luciferase in Doublecortin+ (Dcx) neur...
Abstract Background Rat models of Parkinson’s disease...
Abstract Background Rat models of Parkinson’s disease...
alpha-Synuclein is a soluble, cellular protein that in a number of neurodegenerative diseases, inclu...
Abstract Background Experimental autoimmune encephalomyelitis is a widely used animal model to under...
Alpha-synuclein (αSyn) is encoded by the first causal gene identified in Parkinson's disease (PD) an...
With more than thousand disorders of the brain and nervous system, affecting up to one billion peopl...
With more than thousand disorders of the brain and nervous system, affecting up to one billion peopl...
Parkinson's disease is a neurodegenerative disorder affecting the doparminergic neurons in the subst...
Alpha-synuclein (αSYN) aggregation plays a pivotal role in the pathogenesis of Parkinson's disease a...
Abstract Background Parkinson’s disease (PD) is a neurodegenerative disease characterized by intrane...
International audienceIn Parkinson's disease, some of the first alpha-synuclein aggregates appear in...
Abstract Abnormal accumulation of alpha-synuclein (αsyn) is a pathological hallmark of Lewy body rel...
International audienceIn Parkinson's disease, some of the first alpha-synuclein aggregates appear in...
In Parkinson's disease, some of the first alpha-synuclein aggregates appear in the olfactory system ...